Lemon Healthcare has outlined its vision to become a key platform company in the medical AI era by building an infrastructure that connects medical data.
Hong Byeong-jin, CEO of Lemon Healthcare, stated at a press conference on June 17 at the Conrad Hotel in Yeouido, "Lemon Healthcare is a digital healthcare company that creates new value by connecting, utilizing, and relaying medical data in real-time. We are growing into a relay infrastructure company that enables medical data to move freely."
The company boasts its core technology, the Lemon Digital Bridge (LDB), a real-time, two-way medical data relay platform that connects hospitals, patients, insurance companies, and public institutions. It standardizes diverse medical data from different hospitals and delivers it in real-time to the necessary entities.
Currently, Lemon Healthcare has secured 38 out of 47 top general hospitals in South Korea as clients, achieving over 80% market share. The cumulative downloads of its patient-oriented smart hospital app have surpassed 13 million.
The company highlighted its competitive edge by participating in the construction of Silson24, a computerized platform for health insurance claims, which has established nationwide medical data relay capabilities. The cumulative number of subscribers to its claims service, Claim Genie, has exceeded 1.9 million, with over 10 million claims processed.
Hong noted, "We have accumulated over 100 million medical data records and are evolving beyond a medical data relay platform into a data-based business through data processing and distribution."
Following its IPO, the company plans to establish a marketplace for medical AI training data, aiming to grow as a data trading platform provider that supplies high-quality medical AI training data to AI companies, universities, and research institutions.
"We are not a company that develops medical AI models; we are a company that connects and supplies the data needed by medical AI companies," Hong stated, adding that they will build essential data distribution infrastructure for the medical AI era.
Additionally, the company plans to expand new digital healthcare services such as remote consultations, electronic prescription delivery, and mobile issuance of medical images in response to regulatory changes regarding telemedicine and the use of medical data.
Lemon Healthcare intends to use the funds raised from its IPO to develop the medical AI training data marketplace and new digital healthcare services.
Meanwhile, Lemon Healthcare is offering 2 million shares for public subscription, with a proposed price range of 7,500 to 10,000 won, aiming to raise between 15 billion and 20 billion won. Demand forecasting will take place until June 19, with general subscriptions scheduled for June 24-25. KB Securities is the lead underwriter for the IPO.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.